ALPHA & OMEGA SEMICONDUCTOR Ltd — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ALPHA & OMEGA SEMICONDUCTOR Ltd filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Jun 30, 2012 | $342.29M | Aug 31, 2012 |
| FY2012 | Jun 30, 2011 | $361.31M | Aug 31, 2012 |
| FY2012 | Jun 30, 2010 | $301.84M | Aug 31, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $696.16M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $657.27M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $691.32M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $777.55M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $656.90M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $464.91M | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | $450.92M | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | $421.55M | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | $383.34M | Aug 23, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $161.00M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $171.92M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $199.54M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $268.56M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $204.54M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $102.73M | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | $115.38M | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | $111.93M | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | $91.82M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $65.82M | Aug 23, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($96.98M) | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | ($11.08M) | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $12.36M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $453.16M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $58.12M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | ($6.60M) | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | $1.86M | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | $14.26M | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | $13.83M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | ($2.93M) | Aug 23, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($28.44M) | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | ($3.76M) | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $22.53M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $102.04M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $64.08M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | ($13.94M) | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | ($7.02M) | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | $8.42M | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | $13.14M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $1.51M | Aug 23, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $94.27M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $89.94M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $88.15M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $71.26M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $62.95M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $51.25M | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | $46.43M | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | $37.34M | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | $29.84M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $26.01M | Aug 23, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $95.18M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $85.73M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $88.86M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $95.26M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $77.51M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $64.82M | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | $75.97M | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | $66.16M | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | $48.84M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $37.87M | Aug 23, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $29.67M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $25.71M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $20.47M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $218.87M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $128.74M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $62.32M | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | $31.42M | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | $3.48M | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | $42.65M | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $40.18M | Aug 23, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $37.18M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $37.09M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $110.43M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $138.01M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $72.70M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $62.40M | Sep 20, 2022 |
| FY2016 | Jun 30, 2016 | $21.90M | Feb 1, 2017 |
| FY2016 | Jun 30, 2015 | $21.49M | Feb 1, 2017 |
| FY2016 | Jun 30, 2014 | $9.40M | Feb 1, 2017 |
| FY2015 | Jun 30, 2013 | $17.57M | Mar 22, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.03B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $1.15B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $1.20B | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $1.30B | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $918.57M | Sep 20, 2022 |
| FY2021 | Jun 30, 2020 | $792.94M | Aug 30, 2021 |
| FY2020 | Jun 30, 2019 | $739.39M | Sep 2, 2020 |
| FY2019 | Jun 30, 2018 | $667.05M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $398.41M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $318.51M | Sep 5, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $211.97M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $253.41M | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $315.82M | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $444.54M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $402.25M | Sep 20, 2022 |
| FY2021 | Jun 30, 2020 | $361.05M | Aug 30, 2021 |
| FY2020 | Jun 30, 2019 | $296.11M | Sep 2, 2020 |
| FY2019 | Jun 30, 2018 | $240.89M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $99.86M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $76.47M | Sep 5, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $822.33M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $891.61M | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $883.92M | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $854.09M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $373.21M | Sep 20, 2022 |
| FY2021 | Jun 30, 2020 | $293.69M | Aug 30, 2021 |
| FY2020 | Jun 30, 2019 | $291.02M | Sep 2, 2020 |
| FY2019 | Jun 30, 2018 | $278.59M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $270.77M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $242.14M | Sep 5, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $269.0K | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $269.0K | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $269.0K | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $269.0K | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $269.0K | Sep 20, 2022 |
| FY2021 | Jun 30, 2020 | $269.0K | Aug 30, 2021 |
| FY2020 | Jun 30, 2019 | $269.0K | Sep 2, 2020 |
| FY2019 | Jun 30, 2018 | $269.0K | Aug 23, 2019 |
| FY2019 | Jun 30, 2017 | $300.0K | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | $300.0K | Aug 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $533.93M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $631.06M | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $642.29M | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | $629.99M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $176.90M | Sep 20, 2022 |
| FY2021 | Jun 30, 2020 | $118.83M | Aug 30, 2021 |
| FY2020 | Jun 30, 2019 | $125.49M | Sep 2, 2020 |
| FY2019 | Jun 30, 2018 | $122.64M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $113.91M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $100.07M | Sep 5, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $153.08M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $175.13M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $195.19M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $314.35M | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | $202.41M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $158.54M | Sep 20, 2022 |
| FY2020 | Jun 30, 2019 | $121.89M | Sep 2, 2020 |
| FY2019 | Jun 30, 2018 | $131.54M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $115.71M | Aug 23, 2018 |
| FY2018 | Jun 30, 2016 | $87.77M | Aug 23, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $14.87M | Aug 28, 2025 |
| FY2024 | Jun 30, 2024 | $26.72M | Aug 23, 2024 |
| FY2023 | Jun 30, 2023 | $38.36M | Aug 29, 2023 |
| FY2022 | Jun 30, 2022 | $42.49M | Sep 20, 2022 |
| FY2021 | Jun 30, 2021 | $77.99M | Aug 30, 2021 |
| FY2020 | Jun 30, 2020 | $129.89M | Sep 2, 2020 |
| FY2019 | Jun 30, 2019 | $85.99M | Aug 23, 2019 |
| FY2018 | Jun 30, 2018 | $30.60M | Aug 23, 2018 |
| FY2012 | Jun 30, 2012 | $16.43M | Aug 31, 2012 |
| FY2012 | Jun 30, 2011 | $0 | Aug 31, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (3) | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | 16 | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | 2 | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | 0 | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | 0 | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | 0 | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | 0 | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | 0 | Aug 23, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (3) | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | 16 | Aug 23, 2024 |
| FY2023 | Jun 30, 2021 | 2 | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | 0 | Sep 20, 2022 |
| FY2021 | Jun 30, 2019 | 0 | Aug 30, 2021 |
| FY2020 | Jun 30, 2018 | 0 | Sep 2, 2020 |
| FY2019 | Jun 30, 2017 | 0 | Aug 23, 2019 |
| FY2018 | Jun 30, 2016 | 0 | Aug 23, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 30.01M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | 28.97M | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | 27.65M | Aug 23, 2024 |
| FY2023 | Jun 30, 2022 | 27.37M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | 26.35M | Sep 20, 2022 |
| FY2021 | Jun 30, 2020 | 25.31M | Aug 30, 2021 |
| FY2020 | Jun 30, 2019 | 24.52M | Sep 2, 2020 |
| FY2019 | Jun 30, 2018 | 23.86M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | 23.99M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | 22.75M | Sep 5, 2017 |